Mr. Murray attended the University of New Mexico, where he played Division I baseball and was a Rhodes Scholar Finalist. He graduated as class Valedictorian with a degree in mechanical engineering. He went on to study at Harvard Business School where he graduated in the top five percent of his class. Before joining Eurofins, Mr. Murray led numerous organizations in innovation, business development, and as a GM. His various experiences include R&D at Stryker Instruments and strategy consulting for McKinsey & Company. Most recently, Mr. Murray led a startup business unit at Worthington Industries which he grew from 1 employee to over 300. There, he spent time as Managing Director of the business's European joint venture while living in Istanbul, later becoming General Manager of the global business unit.
"We are excited to have such a dynamic leader on board as our business is constantly adapting to serve the needs of our stakeholders," said David W. Bryant, Group Senior Vice President of Eurofins for North American Food and Environment Testing. "Sean's exceptional track record of success in all personal pursuits and his well-rounded business achievements will be invaluable to Eurofins as the US Food Division grows rapidly in the coming years."
Eurofins provides food testing services including comprehensive chemistry and microbiological testing with food safety auditing according to globally recognized and benchmarked industry standards. In light of the growing demands that are being placed on food producers, processors, and importers, Eurofins has focused on bolstering its unparalleled portfolio of support services with innovative analytical technologies. This approach will provide the food industry with even greater strategic leadership in developing scientific solutions for food safety and quality compliance.
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With over 25,000 staff in more than 250 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities and healthcare practitioners around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.
Logo - http://photos.prnewswire.com/prnh/20160209/331126LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clarification-on-eurofins-scientific-inc-us-announcement-of-the-appointment-of-sean-murray-300375399.html